ACTIVE

ATB THERAPEUTICS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-8 M €-143,2 %over 1 year

Gross margin-513,2 k €+42,0 %over 1 year

Equity5,1 M €-61,1 %over 1 year

Workforce17,0 ETP+77,1 %over 1 year

Identity

Source · BCE/KBO

ATB THERAPEUTICS is a Public limited company incorporated in 2017. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Marche-en-Famenne. It employs on average 17,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0677.980.015
Incorporation: 06/07/2017
Legal form: Public limited company
Registered office: Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital: 20 613 695,66 €
Latest accounts: 31/12/2025
Average workforce: 17,0 ETP

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 72101Research and experimental development on natural sciences and engineering 72110Research and experimental development on biotechnology 01280Growing of spices, aromatic, drug and pharmaceutical crops 01280Growing of spices, aromatic, drug and pharmaceutical crops+2

Joint committees (1)

Signals

Solid equityGood liquidity

Financials

Source · NBB, 8 filings

Trend over 7 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-513,2 k €	+42.0%	-885,1 k €	-1636%	-51 k €	-113%	407,1 k €	+223%	126 k €
EBITDA	-2,4 M €	-44.1%	-1,7 M €	-113%	-785,2 k €	-63.4%	-480,6 k €	+23.3%	-626,6 k €
Operating result	-8,2 M €	-170%	-3 M €	-11.3%	-2,7 M €	+4.7%	-2,9 M €	-25.0%	-2,3 M €
Net result	-8 M €	-143%	-3,3 M €	-54.5%	-2,1 M €	-57.5%	-1,4 M €	-12.6%	-1,2 M €
Balance sheet
Equity	5,1 M €	-61.1%	13,1 M €	+514%	-3,2 M €	-206%	-1 M €	-427%	316 k €
Total assets	10,6 M €	-24.2%	14 M €	+554%	2,1 M €	-1.7%	2,2 M €	-9.0%	2,4 M €
Cash	1,9 M €	-86.2%	13,5 M €	+1280%	978,6 k €	+7.7%	908,2 k €	-31.2%	1,3 M €
Debts	5,6 M €	+482%	955,5 k €	-80.8%	5 M €	+60.9%	3,1 M €	+50.9%	2 M €
Other
Workforce	17,0 ETP	+77.1%	9,6 ETP	-15.8%	11,4 ETP	-15.6%	13,5 ETP	+1.5%	13,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 9 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CHITON ROCKSRepresented by Mark Throsby	Director18/10/2024 → 21/06/2030
LSP 7 Coöperatief U.A.1000.996.943Represented by John de Koning	Director18/10/2024 → 21/06/2030
MAGMAN0743.431.061Represented by Bertrand Magy	Managing director12/11/2019 → 21/06/2030Director29/09/2021 → 2023 accountsended
MRL Ventures Fund LLC1015.281.281Represented by Karin Kleinhans	Director18/10/2024 → 21/06/2030
ORSA ADMIN0890.073.384Represented by Pierre Detrixhe	Director12/11/2019 → 21/06/2030
V-Bio Fund 20759.685.291Represented by Willem Broekaert	Director18/10/2024 → 21/06/2030

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Werner Cautreels	Director26/06/2020 → 2023 accounts
NOSHAQ PARTNERS0808.219.836Represented by BRANDT ERIC	Director16/12/2019 → 2023 accounts
Bertrand Jean Henry MAGY	Managing director12/11/2019 → 2019 accounts

Other companies at this address

Aye, Rue de la Science 8 6900 Marche-en-Famenne

Company	CBE no.
AGRICELLS● Active	0742.991.393
ALEXEIA● Active	1043.223.221
Association pour le développement des Productions Agroalimentaires de qualité● Active	0416.914.413
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne● Active	0457.901.762
ASSOCIATION POUR L'USAGE ET LA DEFENSE DU SAUCISSON D'ARDENNE● Active	0863.356.814
Bureau d’Administration ATB THERAPEUTICS● Active	1031.100.991
CER-Groupe● Active	0420.654.158
INVESTY CORPORATE● Active	1008.960.841
LivingMed Biotech● Active	0748.443.684
Orgenesis (Belgium)● Bankrupt	0540.866.555
ORGENESIS SERVICES SRL● Bankrupt	0790.353.624
RevaTis● Active	0541.682.642
REVATIS VET● Active	1015.868.627
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)● Active	0731.712.273

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/07/2026	14/07/2025	15/07/2024	30/06/2023	30/08/2022	25/11/2021
General meeting	19/06/2026	27/06/2025	21/06/2024	16/06/2023	23/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/06/2026	20/07/2026	French	PDF
Abridged model	31/12/2024	27/06/2025	14/07/2025	French	PDF
Abridged model	31/12/2023	21/06/2024	15/07/2024	French	PDF
Abridged model	31/12/2022	16/06/2023	30/06/2023	French	PDF
Abridged model	31/12/2021	23/06/2022	30/08/2022	French	PDF
Micro model	31/12/2020	18/06/2021	25/11/2021	French	PDF
Micro model	31/12/2019	19/06/2020	03/07/2020	French	PDF
Micro model	31/12/2018	21/06/2019	11/07/2019	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 9 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CHITON ROCKSRepresented by Mark Throsby	Director18/10/2024 → 21/06/2030
LSP 7 Coöperatief U.A.1000.996.943Represented by John de Koning	Director18/10/2024 → 21/06/2030
MAGMAN0743.431.061Represented by Bertrand Magy	Managing director12/11/2019 → 21/06/2030Director29/09/2021 → 2023 accountsended
MRL Ventures Fund LLC1015.281.281Represented by Karin Kleinhans	Director18/10/2024 → 21/06/2030
ORSA ADMIN0890.073.384Represented by Pierre Detrixhe	Director12/11/2019 → 21/06/2030
V-Bio Fund 20759.685.291Represented by Willem Broekaert	Director18/10/2024 → 21/06/2030

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Werner Cautreels	Director26/06/2020 → 2023 accounts
NOSHAQ PARTNERS0808.219.836Represented by BRANDT ERIC	Director16/12/2019 → 2023 accounts
Bertrand Jean Henry MAGY	Managing director12/11/2019 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other26/08/2026
STATUTS (TRADUCTION, COORDINATION, AUTRES
PDF
Capital / shares26/08/2026
CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION,
PDF
Capital / shares13/04/2026
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Capital / shares13/04/2026
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Capital / shares07/07/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates31/10/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates06/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates11/09/2023
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings7 filings

Mandates

MAGMAN

V-Bio Fund 2

ORSA ADMIN

LSP 7 Coöperatief U.A.

MRL Ventures Fund LLC

CHITON ROCKS

Werner Cautreels

NOSHAQ PARTNERS

ViaNova

Fondation Fournier Majoie pour l'Innovation

Bertrand Jean Henry MAGY

Max Houry

Show the 3 other mandates

20172018201920202021202220232024202520262027202820292030

ATB THERAPEUTICS

Aye, Rue de la Science 8, 6900 Marche-en-Famenne

Managing directorDirector

Director

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Aye, Rue de la Science 8, 6900 Marche-en-FamenneCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00324453

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
ATB THERAPEUTICSCurrent	accounts 2018 → 2025	Accounts 2025 · 2026-00324453

Events

2025
Annual accounts 2025-8 M €↓
2024
Annual accounts 2024-3,3 M €↓
2023
Annual accounts 2023-2,1 M €↓
2022
Annual accounts 2022-1,4 M €↓
2021
Annual accounts 2021-1,2 M €↓
2019
Annual accounts 2019-264,7 k €↓
2018
Annual accounts 2018-164,3 k €
06/07/2017
IncorporationPublic limited company

ATB THERAPEUTICS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events